Trial intelligence / Profile preview

Phase II Temozolomide in Relapsed or Refractory Small Cell Lung Cancer with MGMT Methylation (GOPAV03)

2013-003150-25Phase 2Terminated

Sponsor

Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"

Start

Nov 2014

Modality

Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1